| AMPK | AMP-activated protein kinase |
| BC | Bioactive compounds |
| COX-2 | Cyclooxygenase-2 |
| DHA | Docosahexaenoic acid |
| EGCG | Epigallocatechin gallate |
| EPA | Eicosapentaenoic acid |
| HO-1 | Heme oxygenase-1 |
| IBD | Inflammatory bowel disease |
| IL | Interleukin |
| iNOS | Inducible nitric oxide synthase |
| JAK/STAT | Janus kinase/signal transducer and activator of transcription |
| Keap1 | Kelch-like ECH-associated protein 1 |
| LPS | Lipopolysaccharide |
| MAPK | Mitogen-activated protein kinase |
| mTOR | Mechanistic target of rapamycin |
| NCDs | Non-communicable diseases |
| NF-κB | Nuclear factor kappa B |
| NLRP3 | NOD-like receptor family pyrin domain-containing protein 3 |
| NQO1 | NAD(P)H quinone oxidoreductase 1 |
| Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| PPARs | Peroxisome proliferator-activated receptors |
| PUFA | Polyunsaturated fatty acids |
| ROS | Reactive oxygen species |
| SCFAs | Short-chain fatty acids |
| SIRT1 | Sirtuin 1 |
| T2DM | Type 2 diabetes mellitus |
| TNF | Tumor necrosis factor |
| VCAM-1 | Vascular cell adhesion molecule-1 |
| ω-3 PUFA | Omega-3 polyunsaturated fatty acids |